Works matching IS 25233548 AND DT 2021 AND VI 41 AND IP 11


Results: 18
    1
    2

    Additional Cover.

    Published in:
    Cancer Communications, 2021, v. 41, n. 11, p. 1, doi. 10.1002/cac2.12246
    Publication type:
    Article
    3

    Featured Cover.

    Published in:
    Cancer Communications, 2021, v. 41, n. 11, p. 1, doi. 10.1002/cac2.12245
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10

    The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.

    Published in:
    Cancer Communications, 2021, v. 41, n. 11, p. 1195, doi. 10.1002/cac2.12218
    By:
    • Tang, Ling‐Long;
    • Chen, Yu‐Pei;
    • Chen, Chuan‐Ben;
    • Chen, Ming‐Yuan;
    • Chen, Nian‐Yong;
    • Chen, Xiao‐Zhong;
    • Du, Xiao‐Jing;
    • Fang, Wen‐Feng;
    • Feng, Mei;
    • Gao, Jin;
    • Han, Fei;
    • He, Xia;
    • Hu, Chao‐Su;
    • Hu, De‐sheng;
    • Hu, Guang‐Yuan;
    • Jiang, Hao;
    • Jiang, Wei;
    • Jin, Feng;
    • Lang, Jin‐Yi;
    • Li, Jin‐Gao
    Publication type:
    Article
    11
    12

    Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study.

    Published in:
    Cancer Communications, 2021, v. 41, n. 11, p. 1173, doi. 10.1002/cac2.12214
    By:
    • Peng, Zhi;
    • Liu, Tianshu;
    • Wei, Jia;
    • Wang, Airong;
    • He, Yifu;
    • Yang, Liuzhong;
    • Zhang, Xizhi;
    • Fan, Nanfeng;
    • Luo, Suxia;
    • Li, Zhen;
    • Gu, Kangsheng;
    • Lu, Jianwei;
    • Xu, Jianming;
    • Fan, Qingxia;
    • Xu, Ruihua;
    • Zhang, Liangming;
    • Li, Enxiao;
    • Sun, Yuping;
    • Yu, Guohua;
    • Bai, Chunmei
    Publication type:
    Article
    13
    14
    16
    17
    18

    Issue Information.

    Published in:
    Cancer Communications, 2021, v. 41, n. 11, p. 1079, doi. 10.1002/cac2.12061
    Publication type:
    Article